Road traffic accidents and psychotropic medication use in the Netherlands: A case-control study

British Journal of Clinical Pharmacology

Volumn 72, Issue 3, 2011, Pages 505-513

  Ravera, Silvia ^a   van Rein, Nienke ^a   de Gier, Johan J ^a   de Jong van den Berg, Lolkje T W ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Case control study; Pharmacoepidemiology; Psychotropic medications; Road traffic accidents

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC SEDATIVE AGENT; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CONTROLLED STUDY; DRIVING ABILITY; DRUG EXPOSURE; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; SIDE EFFECT; TRAFFIC ACCIDENT; TRAFFIC SAFETY;

ACCIDENTS, TRAFFIC; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ANTI-ANXIETY AGENTS; AUTOMOBILE DRIVING; CASE-CONTROL STUDIES; DATABASES, FACTUAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG UTILIZATION; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; NETHERLANDS; PSYCHOTROPIC DRUGS; REGRESSION ANALYSIS; RISK FACTORS; YOUNG ADULT;

EID: 79960248726     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2011.03994.x     Document Type: Article

References (58)

1. Drummer OH, Gerostamoulos J, Batziris H, Chu M, Caplehorn J, Robertson MD, Swann P. The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes. Accident Anal Prev 2004; 36: 239-48.
2. European Commission. Road Safety - Fitness to Drive. Available at (last accessed 15 October 2010).
3. Canadian Traffic Injury Research Foundation and Palmer SA. Drugs and driving: a compendium of research studies. Available at (last accessed 15 October 2010).
4. Walsh JM, de Gier JJ, Christopherson AS, Verstraete AG. Drugs and driving. Traffic Inj Prev 2004; 5: 241-53.
5. Orriols L, Salmi LR, Philip P, Moore N, Delorme B, Castot A, Lagarde E. The impact of medicinal drugs on traffic safety: a systematic review of epidemiological studies. Pharmacoepidemiol Drug Saf 2009; 18: 647-58.
6. del Río MC, Gómez J, Sancho M, Alvarez FJ. Alcohol, illicit drugs and medicinal drugs in fatally injured drivers in Spain between 1991 and 2000. Forensic Sci Int 2002; 127: 63-70.
7. Raes E, van den Neste T, Verstraete AG. EMCDDA Insights Series no. 8: Drug use, impaired driving and traffic accidents. 2008. EMCDDA, Lisbon, Portugal. Available at (last accessed 15 October 2010).
8. European Monitoring Centre for Drugs and Drug Addiction. Literature review on the relation between drug use, impaired driving and traffic accidents (CT.97.EP.14). 1999. EMCDDA, Lisbon, Portugal. Available at (last accessed 19 October 2010).
9. Various authors. Rijden onder invloed. Pharm Weekblad 2009; 144: 18. Available at (last accessed 12 October 2010).
10. Orriols L, Delorme B, Gadegbeku B, Tricotel A, Contrand B, Laumon B, Salmi LR. Lagarde E, and the CESIR research group. Prescription medicines and the risk of road traffic crashes: a French registry-based study. PLoS Med 2010; 7: e1000366.
11. Drummer OH. The role of drugs in road safety. Aust Prescr 2008; 31: 33-5.
12. Barbone F, McMahon AD, Davey PG, Morris AD, Reid IC, McDevitt DG, MacDonald TM. Association of road-traffic accidents with benzodiazepine use. Lancet 1998; 352: 1331-6.
13. Engeland A, Skurtveit S, Mørland J. Risk of road traffic accidents associated with the prescription of drugs: a registry-based cohort study. Ann Epidemiol 2007; 17: 597-602.
14. Movig KLL, Mathijssen MPM, Nagel PHA, van Egmond T, de Gier JJ, Leufkens HGM, Egberts ACG. Psychoactive substance use and the risk of motor vehicle accidents. Accident Anal Prev 2004; 36: 631-6.
15. Berghaus G, Hilgers RD. Measurement and methods to determine driving ability. In: Drugs, Driving and Traffic Safety, eds Verster JC, Pandi-Perumal SR, Ramaekers JG, de Gier JJ. Basel, Boston, Berlin: Birkäuser Verlag/Switzerland, 2009; 59-74.
16. Houwing S, Mathijssen R, Brookhuis KA. Case-control studies. In: Drugs, Driving and Traffic Safety, eds Verster JC, Pandi-Perumal SR, Ramaekers JG, de Gier JJ. Basel, Boston, Berlin: Birkäuser Verlag/Switzerland, 2009; 107-20.
17. Bramness JG, Skurtveit S, Neutel CI, Mørland J, Engeland A. Minor increase in risk of road traffic accidents after prescriptions of antidepressants: a study of population registry data in Norway. J Clin Psychiat 2008; 69: 1099-103.
18. PHARMO Institute. Available at (last accessed 6 October 2010).
19. Kalverdijk LJ, Tobi H, van den Berg PB, Buiskool J, Wagenaar L, Minderaa RB, de Jong-van den Berg LTW. Use of antipsychotics drugs among Dutch youth between 1997 and 2005. Psychiatr Serv 2008; 59: 554-60.
20. Ravera S, Visser ST, de Gier JJ, de Jong-van den Berg LTW. Prevalence, cumulative incidence, monotherapy and combination therapy, and treatment duration of frequently prescribed psychoactive medications in the Netherlands: retrospective database analysis for the years 2000 to 2005. Clin Ther 2010; 32: 2457-66.
21. WHO Collaborating Centre for Drug Statistics Methodology - ATC/DDD Index 2010. Available at (accessed 6 October 2010).
22. Dienst Verkeer en Scheepvaart (DVS). Available at (last accessed 12 October 2010).
23. Rijks Dienst Wegverkeer (RDW). Available at (last accessed 12 October 2010).
24. van Herk-Sukel MPP, van de Poll-Franse LV, Lemmens VEPP, Vreugdenhil G, Pruijt JFM, Coebergh JWW, Herings RMC. New opportunities for drug outcomes research in cancer patients: the linkage of the Eindhoven Cancer Registry and the PHARMO Record Linkage System. Eur J Cancer 2010; 46: 395-404.
25. Herings RMC. PHARMO: a record linkage system for postmarketing surveillance of prescription drugs in the Netherlands. Thesis (Doctorate). Utrecht University; 1993.
26. Trevor AJ, Way WL. Sedative-hypnotic drugs. In: Basic and Clinical Pharmacology, Eighth edn. ed. Katzung BG. New York: Lange Medical Books/McGraw-Hill, 2001; 364-81.
27. Verster JC, Ramaekers JG. Antidepressants and traffic safety. In: Drugs, Driving and Traffic Safety, eds Verster JC, Pandi-Perumal SR, Ramaekers JG, de Gier JJ. Basel, Boston, Berlin: Birkäuser Verlag/Switzerland, 2009; 307-14.
28. Rapoport MJ, Molnar F, Rochon PA, Juurlink DN, Zagorski B, Seitz D, Morris JC, Redelmeier DA. Psychotropic medications and motor vehicle collisions in patients with dementia. J Am Geriatr Soc 2008; 56: 1968-9.
29. Hooper TI, DeBakey SF, Pearse L, Pratt S, Hoffman KJ. The use of electronic pharmacy data to investigate prescribed medications and fatal motor vehicle crashes in a military population, 2000-2006. Accident Anal Prev 2010; 42: 261-8.
30. Hampton T. Suicide caution stamped on antidepressants. JAMA 2004; 291: 2060-1.
31. Teicher MH, Glod CA, Cole OJ. Antidepressant drugs and the emergence of suicidal tendencies. Drug Saf 1998; 8: 186-212.
32. American Psychiatric Association. In: Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Text Revision (DSM-IV-TR). Washington, DC: APA, 2000.
33. Wessely S, Kerwin R. Suicide risk and the SSRIs. JAMA 2004; 292: 379-81.
34. Neutel CI, Patten SB. Risk of suicide attempts after benzodiazepine and/or antidepressant use. Ann Epidemiol 1997; 7: 568-74.
35. Leveille SG, Buchner DM, Koepsell TD, McCloskey LW, Wolf ME, Wagner EH. Psychoactive medications and injurious motor vehicle collisions involving older drivers. Epidemiology 1994; 5: 591-8.
36. Agence française de sécurité sanitaire des produits de santé (AFSSAPS) - Medicinal products and driving (02/07/2009). Available at (last accessed 15 October 2010).
37. Rapoport MJ, Baniña MC. Impact of psychotropic medications on simulated driving - A critical review. CNS Drugs 2007; 21: 503-19.
38. Noël PH, Williams JW, Unützer J, Worchel J, Lee S, Cornell J, Katon W, Harpole LH, Hunkeler E. Depression and comorbid illness in elderly primary care patients: impact on multiple domains of health status and well-being. Ann Fam Med 2004; 2: 555-62.
39. Hansen HV, Kessing LV. Adherence to antidepressant treatment. Expert Rev Neurother 2007; 7: 57-62.
40. Bulloch AG, Patten SB. Non-adherence with psychotropic medications in the general population. Soc Psychiatry Psychiatr Epidemiol 2010; 45: 47-56.
41. Farmacotherapeutisch Kompas (in Dutch). Available at (last accessed 15 October 2010).
42. de Gier JJ, Alvarez FJ, Mercier-Guyon C, Verstraete AG. Prescribing and dispensing guidelines for medicinal drugs affecting driving performance. In: Drugs, Driving and Traffic Safety, eds Verster JC, Pandi-Perumal SR, Ramaekers JG, de Gier JJ. Basel, Boston, Berlin: Birkäuser Verlag/Switzerland, 2009; 121-34.
43. Wingen M, Ramaekers JG, Schmitt JAJ. Driving impairment in depressed patients receiving long-term antidepressant treatment. Psychopharmacology 2006; 188: 84-91.
44. Verster JC, Mets MAJ, Leufkens TRM, Vermeeren A. Insomnia, hypnotic drugs and traffic safety. In: Drugs, Driving and Traffic Safety, eds Verster JC, Pandi-Perumal SR, Ramaekers JG, de Gier JJ. Basel, Boston, Berlin: Birkäuser Verlag/Switzerland, 2009; 233-44.
45. Hemmelgarn B, Suissa S, Huang A, Boivin JF, Pinard G. Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA 1997; 278: 27-31.
46. Neutel CI. Benzodiazepine-related traffic accidents in young and elderly drivers. Hum Psychopharmacol 1998; 13: S115-23.
47. Dubois S, Bédard M, Weaver B. The impact of benzodiazepines on safe driving. Traffic Inj Prev 2008; 9: 404-13.
48. van Laar MW, Volkerts ER. Driving and benzodiazepine use - Evidence that they do not mix. CNS Drugs 1998; 10: 383-96.
49. Neutel CI. Risk of traffic accident injury after a prescription for a benzodiazepine. Ann Epidemiol 1995; 5: 239-44.
50. Gandhi M, Aweeka F, Greenblatt RM, Blaschke TF. Sex differences and pharmacokinetics and pharmacodynamics. Annu Rev Pharmacol 2004; 44: 499-523.
51. Rademaker M. Do women have more adverse drug reactions? Am J Clin Dermatol 2001; 2: 349-51.
52. Li G, Baker SP, Langlois JA, Kelen GD. Are female drivers safer? An application of the decomposition method. Epidemiology 1998; 9: 379-84.
53. Massie DL, Campbell KL, Williams AF. Traffic accident involvement rates by driver age and gender. Accident Anal Prev 1995; 27: 73-87.
54. Deffenbacher JL, Lynch RS, Filetti LB, Dahlen ER, Oetting ER. Anger, aggression, risky behaviour, and crash related outcomes in three groups of drivers. Behav Res Ther 2003; 41: 333-49.
55. Vermeeren A, Leufkens TRM, Verster JC. Effects of anxiolytics on driving. In: Drugs, Driving and Traffic Safety, eds Verster JC, Pandi-Perumal SR, Ramaekers JG, de Gier JJ. Basel, Boston, Berlin: Birkäuser Verlag/Switzerland, 2009; 289-306.
56. Tavris DR, Kuhn EM, Layde PM. Age and gender patterns in motor vehicle crash injuries: importance of type of crash and occupant role. Accident Anal Prev 2001; 33: 167-72.
57. Gustavsen I, Bramness JG, Skurtveit S, Engeland A, Neutel I, Mørland J. Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. Sleep Med 2008; 9: 818-22.
58. Bramness JG, Skurtveit S, Mørland J. Clinical impairment of benzodiazepines - relation between benzodiazepine concentrations and impairment in apprehended drivers. Drug Alcohol Depen 2002; 68: 131-41.